内布拉斯加医学公司撤销了关于8亿美元销售的诉讼，目标是在新治理下于6月30日关闭。 Nebraska Medicine drops lawsuit over $800M sale, aiming for June 30 closing under new governance.

内布拉斯加医学公司已提出诉讼,要求撤销对内布拉斯加大学摄政委员会和克拉克森地区卫生服务公司的诉讼,涉及一笔8亿美元的交易,以转移医院的全部所有权。 Nebraska Medicine has filed to dismiss its lawsuit against the University of Nebraska Board of Regents and Clarkson Regional Health Services over an $800 million deal to transfer full ownership of the hospital. 该诉讼案在执政者批准出售并取代医院董事会后提出,对交易的合法性提出质疑。 The lawsuit, filed after the regents approved the sale and replaced the hospital’s board, questioned the transaction’s legality. 现在,该医院试图在新的单一成员治理结构下向前迈进,预计6月30日将结束这笔交易。 Now, the hospital seeks to move forward under a new single-member governance structure, with the deal expected to close by June 30. 克拉克森将购买其股份,向大学的“项目健康”倡议捐赠2亿美元,摄政者已任命支持这项交易的新董事会成员。 Clarkson will buy its stake, donate $200 million to the university’s “Project Health” initiative, and the regents have appointed new board members supportive of the deal. 一项拟议的法案LB 1125可能需要立法批准,以便今后购置超过1亿美元的医院,并定于2月19日举行听证会。 A proposed bill, LB 1125, could require legislative approval for future hospital acquisitions over $100 million and is set for a February 19 hearing.